Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision. The mission of the VRAI is to enable the highest quality, standardized efficacy testing of patients with visual impairment. The VRAI facilitates the development and refinement of existing endpoints specifically for testing patients with Low Vision.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of bilateral retinitis pigmentosa (RP) or other retinal dystrophies impacting peripheral vision as confirmed from previous eye examination records
• Best-corrected visual acuity between 20/200 to HM in at least one eye.
• Reasonably fluent in English or Spanish
Locations
United States
California
Vision Research and Assessment Institute
RECRUITING
Irvine
Contact Information
Primary
Reem Jaber, MS, CGC
info@vr-ai.com
949-264-3793
Time Frame
Start Date: 2026-02-19
Estimated Completion Date: 2027-02
Participants
Target number of participants: 25
Treatments
Retinitis Pigmentosa
Up to 25 patients with Retinitis Pigmentosa
Other Retinal Dystrophies
Up to 25 patients with Other Retinal Dystrophies
Related Therapeutic Areas
Sponsors
Leads: Ray Therapeutics, Inc.